Skip to main content

Table 4 Metabolic alterations in ERG Rearrangement-positive PC versus ERG Rearrangement-negative PC

From: Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status

Metabolite

Change in ERG-positive PC

Technique

BH p-valuea

BH p-value for mixed model

BH p-value for mixed model adjusted for Gleason score

BH p-value for mixed model adjusted for percentage of epithelium

BH p-value for mixed model adjusted for percentage of malignancy

Glycerophosphocholine

1H HR MAS NMR

7.05 × 10−3

4.50 × 10−01

7.69 × 10− 01

4.03 × 10− 01

3.79 × 10− 01

O-Phosphocholine

1H HR MAS NMR

2.96 × 10− 2

5.43 × 10− 01

7.47 × 10− 01

5.31 × 10− 01

5.47 × 10− 01

Lysine

1H HR MAS NMR

1.64 × 10− 2

8.85 × 10− 02

6.46 × 10− 01

1.05 × 10− 02

2.00 × 10− 02

Tyrosine

1H HR MAS NMR

8.74 × 10− 3

1.54 × 10− 03

2.40 × 10− 01

1.54 × 10− 03

2.81 × 10− 03

Myo-inositol

1H HR MAS NMR

4.73 × 10−3

3.00 × 10− 02

2.99 × 10− 01

5.09 × 10− 02

5.82 × 10− 02

Valine

1H HR MAS NMR

1.81 × 10− 2

6.91 × 10− 02

6.46 × 10− 01

3.09 × 10− 02

3.54 × 10− 02

Phenylalanine

1H HR MAS NMR

3.52 × 10− 2

1.34 × 10− 02

2.89 × 10− 01

1.39 × 10− 02

2.00 × 10− 02

Hypoxanthine

1H HR MAS NMR

1.71 × 10− 2

8.23 × 10− 02

6.13 × 10− 01

7.59 × 10− 02

4.68 × 10− 02

Ascorbate

1H HR MAS NMR

3.57 × 10− 2

3.20 × 10− 01

7.69 × 10− 01

4.03 × 10− 01

2.81 × 10− 01

Glutathione

1H HR MAS NMR

3.57 × 10− 2

3.66 × 10− 01

7.95 × 10− 01

4.93 × 10− 01

4.03 × 10− 01

Aspartate

1H HR MAS NMR

4.15 × 10− 2

2.74 × 10− 01

7.69 × 10− 01

2.92 × 10− 01

4.28 × 10− 01

Butyrylcarnitine

LC-MS (+)

6.90 × 10− 4

1.63 × 10− 01

3.46 × 10− 01

1.57 × 10− 01

1.57 × 10− 01

Myristoylcarnitine

LC-MS (+)

3.06 × 10− 4

8.85 × 10− 02

1.88 × 10− 01

5.99 × 10− 02

3.76 × 10− 02

Hexanoylcarnitine

LC-MS (+)

6.90 × 10− 4

2.30 × 10− 01

6.08 × 10− 01

2.50 × 10− 01

2.42 × 10− 01

Xanthine

LC-MS (+)

2.84 × 10−4

8.97 × 10− 04

3.42 × 10− 03

1.54 × 10− 03

2.81 × 10− 03

Acetylcarnitine

LC-MS (+)

3.46 × 10− 4

9.15 × 10− 01

3.31 × 10− 01

9.77 × 10− 02

1.12 × 10− 01

Adenine

LC-MS (+)

1.55 × 10− 3

1.75 × 10− 01

2.89 × 10− 01

1.69 × 10− 01

1.57 × 10− 01

Palmitoylcarnitine

LC-MS (+)

2.76 × 10− 3

1.78 × 10− 01

2.89 × 10− 01

1.26 × 10− 01

1.27 × 10− 01

Sphingosine

LC-MS (+)

8.34 × 10− 3

2.75 × 10− 01

6.13 × 10− 01

3.32 × 10− 01

3.08 × 10− 01

Dodecanoylcarnitine

LC-MS (+)

2.58 × 10− 3

2.67 × 10− 01

4.73 × 10− 01

2.92 × 10− 01

2.34 × 10− 01

Oleoylcarnitine

LC-MS (+)

1.70 × 10− 2

4.77 × 10− 01

5.60 × 10− 01

3.61 × 10− 01

3.36 × 10− 01

Stearoylcarnitine

LC-MS (+)

4.26 × 10− 3

1.81 × 10− 01

2.89 × 10− 01

1.25 × 10− 01

1.27 × 10− 01

Inosine

LC-MS (+)

8.44 × 10− 4

1.78 × 10− 01

4.73 × 10− 01

1.80 × 10− 01

1.89 × 10− 01

Propionylcarnitine

LC-MS (+)

2.90 × 10−2

4.05 × 10− 01

7.35 × 10− 01

4.22 × 10− 01

4.03 × 10− 01

Uric acid

LC-MS (+)

2.16 × 10− 3

1.75 × 10− 01

4.73 × 10− 01

1.57 × 10− 01

1.83 × 10− 01

  1. BH Benjamini–Hochberg multiple testing correction; a nonparametric t-test